These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 32791092)

  • 21. A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer.
    Wang Y; Gao S; Xu Y; Tang Z; Liu S
    Sci Rep; 2023 Mar; 13(1):3918. PubMed ID: 36890266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
    Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA.
    Zhang X; Zhang Q; Xie X; Li Y; Pang Z; Yu T
    Biomed Res Int; 2022; 2022():7201963. PubMed ID: 35224098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.
    He Q; Xue S; Wa Q; He M; Feng S; Chen Z; Chen W; Luo X
    Medicine (Baltimore); 2021 Apr; 100(17):e25715. PubMed ID: 33907159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
    Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
    Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of alternative splicing events and prognostic signatures in breast cancer.
    Han P; Zhu J; Feng G; Wang Z; Ding Y
    BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A three-microRNA signature predicts clinical outcome in breast cancer patients.
    Cheng D; He H; Liang B
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6386-6395. PubMed ID: 30338807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
    Yu J; Yang K; Zheng J; Sun X; Zhao W
    Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weighted Gene Coexpression Network Analysis Identifies TBC1D10C as a New Prognostic Biomarker for Breast Cancer.
    Qiao H; Lv R; Pang Y; Yao Z; Zhou X; Zhu W; Zhou W
    Anal Cell Pathol (Amst); 2022; 2022():5259187. PubMed ID: 35425695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.
    Ye Q; Han X; Wu Z
    Bioengineered; 2020 Dec; 11(1):1280-1300. PubMed ID: 33164640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A tumor microenvironment-related risk model for predicting the prognosis and tumor immunity of breast cancer patients.
    Geng S; Fu Y; Fu S; Wu K
    Front Immunol; 2022; 13():927565. PubMed ID: 36059555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a survival-related signature for sarcoma patients through integrated transcriptomic and proteomic profiling analyses.
    Zhang B; Yang L; Wang X; Fu D
    Gene; 2021 Jan; 764():145105. PubMed ID: 32882333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
    Ren H; Hu D; Mao Y; Su X
    Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
    Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
    Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
    Li L; Liu ZP
    J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.